Retention in HIV Oral and Injectable HIV Pre-exposure Prophylaxis (PrEP) Care in Milan, Italy

BACKGROUND: The aims of this study are to estimate retention in HIV PrEP care in a large Italian centre and identify factors associated with discontinuation. SETTING: Tertiary infectious diseases centre in Milan, Italy. METHODS: This is a retrospective study including PrEP users with ≥1 follow-up visit between July 2017-January 2025; follow-up through June 2025. Retention was defined as ongoing follow-up at the centre or confirmed transfer while continuing PrEP; discontinuation as loss to follow-up (>12 months) or documented decision to stop PrEP. Users' characteristics were compared using non-parametrical tests. Kaplan-Meier method was used to assess retention probability. RESULTS: Among 1.781 PrEP users, 1.612 with ≥1 follow-up visit were included (median follow-up 1.7 years, IQR=0.7-2.9). Regimens at initiation were daily FTC/TDF (41.5%), on-demand FTC/TDF (58.3%), and long-acting cabotegravir (0.1%). Over follow-up, 77 users switched to cabotegravir. At data-freeze, 1142/1612 (70.8%) were in active follow-up, 22/1612 (1.4%) had transferred, 357/1612 (22.2%) were lost to follow-up, and 91/1612 (5.7%) had discontinued PrEP. The probability of retention was 84.7% (95%CI=82.9-86.6) at 1 year and 74.9% (95%CI=72.6-77.4) at 2 years. Older age (retained: 35.5 years, IQR=30.7-42.2 vs not retained: 32.9, IQR=28.6-38.0, p<0.001), DoxyPEP use (178/1164, 15.3% vs 17/448, 3.8%, p<0.001) and the number of STIs over follow-up (IRR 1.14, 95%CI=1.02-1.28, p=0.018) were associated with higher retention. CONCLUSION: Retention in this Italian PrEP centre was moderately high. Older individuals and DoxyPEP users were more likely to be retained. These findings support targeted retention strategies and integrated sexual health services to reduce disengagement from PrEP care.

Authors

Institutions

Publication Details

Journal
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2026-11-18
DOI
https://doi.org/10.1097/qai.0000000000004003
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Retention in HIV Oral and Injectable HIV Pre-exposure Prophylaxis (PrEP) Care in Milan, Italy

Camilla Muccini, Riccardo Lolatto, Chiara Maci, Angelo Roberto Raccagni et al.
3 links
JAIDS Journal of Acquired Immune Deficiency Syndromes
HIV/AIDS Research and Interventions
article

Retention in HIV Oral and Injectable HIV Pre-exposure Prophylaxis (PrEP) Care in Milan, Italy

Camilla Muccini, Riccardo Lolatto, Chiara Maci, Angelo Roberto Raccagni, Nicolò Capra, Antonella Castagna, Caterina Candela, Silvia Nozza, Elena Bruzzesi, Gabriele Loi, Antonio Tiani
article en

Abstract

BACKGROUND: The aims of this study are to estimate retention in HIV PrEP care in a large Italian centre and identify factors associated with discontinuation. SETTING: Tertiary infectious diseases centre in Milan, Italy. METHODS: This is a retrospective study including PrEP users with ≥1 follow-up visit between July 2017-January 2025; follow-up through June 2025. Retention was defined as ongoing follow-up at the centre or confirmed transfer while continuing PrEP; discontinuation as loss to follow-up (>12 months) or documented decision to stop PrEP. Users' characteristics were compared using non-parametrical tests. Kaplan-Meier method was used to assess retention probability. RESULTS: Among 1.781 PrEP users, 1.612 with ≥1 follow-up visit were included (median follow-up 1.7 years, IQR=0.7-2.9). Regimens at initiation were daily FTC/TDF (41.5%), on-demand FTC/TDF (58.3%), and long-acting cabotegravir (0.1%). Over follow-up, 77 users switched to cabotegravir. At data-freeze, 1142/1612 (70.8%) were in active follow-up, 22/1612 (1.4%) had transferred, 357/1612 (22.2%) were lost to follow-up, and 91/1612 (5.7%) had discontinued PrEP. The probability of retention was 84.7% (95%CI=82.9-86.6) at 1 year and 74.9% (95%CI=72.6-77.4) at 2 years. Older age (retained: 35.5 years, IQR=30.7-42.2 vs not retained: 32.9, IQR=28.6-38.0, p<0.001), DoxyPEP use (178/1164, 15.3% vs 17/448, 3.8%, p<0.001) and the number of STIs over follow-up (IRR 1.14, 95%CI=1.02-1.28, p=0.018) were associated with higher retention. CONCLUSION: Retention in this Italian PrEP centre was moderately high. Older individuals and DoxyPEP users were more likely to be retained. These findings support targeted retention strategies and integrated sexual health services to reduce disengagement from PrEP care.

JAIDS Journal of Acquired Immune Deficiency Syndromes
Vita-Salute San Raffaele University (IT), IRCCS Ospedale San Raffaele (IT)
Good health and well-being
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon